111 related articles for article (PubMed ID: 15254581)
1. Unbuckling lipodystrophy from insulin resistance and hypertension.
Hegele RA; Leff T
J Clin Invest; 2004 Jul; 114(2):163-5. PubMed ID: 15254581
[TBL] [Abstract][Full Text] [Related]
2. Phenomics, lipodystrophy, and the metabolic syndrome.
Hegele RA
Trends Cardiovasc Med; 2004 May; 14(4):133-7. PubMed ID: 15177263
[TBL] [Abstract][Full Text] [Related]
3. Metabolic consequences of lipodystrophy in mouse models.
Reue K; Phan J
Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):436-41. PubMed ID: 16778573
[TBL] [Abstract][Full Text] [Related]
4. Lessons from human mutations in PPARgamma.
Hegele RA
Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S31-5. PubMed ID: 15711581
[TBL] [Abstract][Full Text] [Related]
5. Role of renin-angiotensin system in adipose tissue dysfunction.
Iwai M; Horiuchi M
Hypertens Res; 2009 Jun; 32(6):425-7. PubMed ID: 19407825
[TBL] [Abstract][Full Text] [Related]
6. Review article: hepatic steatosis and insulin resistance.
Lonardo A; Lombardini S; Ricchi M; Scaglioni F; Loria P
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():64-70. PubMed ID: 16225477
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma and insulin action: insights from human genetics.
Chatterjee VK
Horm Res; 2003; 60 Suppl 3():51-5. PubMed ID: 14671397
[TBL] [Abstract][Full Text] [Related]
8. Mouse models of insulin resistance.
Nandi A; Kitamura Y; Kahn CR; Accili D
Physiol Rev; 2004 Apr; 84(2):623-47. PubMed ID: 15044684
[TBL] [Abstract][Full Text] [Related]
9. In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance.
Haugaard SB; Andersen O; Hansen BR; Andersen UB; Vølund A; Iversen J; Nielsen JO; Madsbad S
Metabolism; 2005 Feb; 54(2):171-9. PubMed ID: 15690310
[TBL] [Abstract][Full Text] [Related]
10. Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.
Tsai YS; Kim HJ; Takahashi N; Kim HS; Hagaman JR; Kim JK; Maeda N
J Clin Invest; 2004 Jul; 114(2):240-9. PubMed ID: 15254591
[TBL] [Abstract][Full Text] [Related]
11. PPARgamma-mediated insulin sensitization: the importance of fat versus muscle.
Kintscher U; Law RE
Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E287-91. PubMed ID: 15637349
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance, the renin-angiotensin system, and associated renal injury: is insulin resistance the culprit?
Ahmed MH
Ren Fail; 2007; 29(1):113-4. PubMed ID: 17365921
[No Abstract] [Full Text] [Related]
13. Acquired and inherited lipodystrophies.
Garg A
N Engl J Med; 2004 Mar; 350(12):1220-34. PubMed ID: 15028826
[No Abstract] [Full Text] [Related]
14. Impact of genetic variation of PPARgamma in humans.
Meirhaeghe A; Amouyel P
Mol Genet Metab; 2004; 83(1-2):93-102. PubMed ID: 15464424
[TBL] [Abstract][Full Text] [Related]
15. Adipose cell-adrenal interactions: current knowledge and future perspectives.
Ronconi V; Turchi F; Bujalska IJ; Giacchetti G; Boscaro M
Trends Endocrinol Metab; 2008 Apr; 19(3):100-3. PubMed ID: 18299203
[TBL] [Abstract][Full Text] [Related]
16. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
[TBL] [Abstract][Full Text] [Related]
17. Vascular oxidative stress is associated with insulin resistance in hyper-reninemic nonmodulating essential hypertension.
Sanchez R; Fischer P; Cuniberti L; Masnatta LD; Ramírez AJ
J Hypertens; 2007 Dec; 25(12):2434-40. PubMed ID: 17984665
[TBL] [Abstract][Full Text] [Related]
18. Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists.
Erbe DV; Gartrell K; Zhang YL; Suri V; Kirincich SJ; Will S; Perreault M; Wang S; Tobin JF
Vascul Pharmacol; 2006 Sep; 45(3):154-62. PubMed ID: 16765099
[TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
Perkins JM; Davis SN
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?
Kino T; Chrousos GP
Ann N Y Acad Sci; 2004 Jun; 1024():153-67. PubMed ID: 15265780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
